[Adoptive immunotherapy with interleukin-2 and with interleukin-2 activated lymphocytes].
Eggermont
A M
AM
Stoter
G
G
Jansen
R L
RL
Bolhuis
R L
RL
D000818:Animals; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated; D008213:Lymphocyte Activation; D051379:Mice; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2
Adoptieve immunotherapie met interleukine-2 en met interleukine-2 geactiveerde lymfocyten.